EPISODE · Jul 29, 2022 · 31 MIN
Use of Novel Therapies in Endometrial Cancer: Update for Managed Care | PTCE Pharmacy Connect
from Pharmacy Podcast Network · host Pharmacy Podcast Network
Accreditation and support statement: · PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit. · This activity is supported by educational grant from GlaxoSmithKline. Objectives • Review the guideline-recommended role of immune-based therapies in the management of endometrial cancer. • Discuss access to care, cost of care and cost-effectiveness of Immune checkpoint inhibitors in the treatment of endometrial cancer. Learn more about your ad choices. Visit megaphone.fm/adchoices
What this episode covers
Accreditation and support statement: · PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit. · This activity is supported by educational grant from GlaxoSmithKline. Objectives • Review the guideline-recommended role of immune-based therapies in the management of endometrial cancer. • Discuss access to care, cost of care and cost-effectiveness of Immune checkpoint inhibitors in the treatment of endometrial cancer. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Use of Novel Therapies in Endometrial Cancer: Update for Managed Care | PTCE Pharmacy Connect
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m